Genomictree

Genomictree, Inc. is a molecular diagnostics company focused on developing epigenomic biomarker-based technologies. The company aims to address unmet needs in the healthcare market by providing innovative diagnostic solutions. Through its research and development efforts, Genomictree seeks to enhance patient care and improve health outcomes by leveraging advanced molecular diagnostic tools.

Ahn Seong-hwan

CEO

2 past transactions

NS Biotechnology

Series A in 2021
NS Biotechnology is a platform technology development company that delivers biomolecules using gold nanoparticle-DNA conjugates.

Optolane

Series B in 2021
Optolane Technologies Inc. is a biotechnology company based in Seongnam, South Korea, founded in 2012. The company specializes in developing portable photo sensor chip-based PCR machines for life science applications. Its diagnostic device offers alternatives for point-of-care testing (POCT) in molecular and immunoassay diagnostics. By integrating optical and thermal control systems, Optolane's semiconductor-based in-vitro diagnostic devices enable real-time and digital PCR, facilitating timely disease diagnosis and enhancing the quality of life for individuals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.